Related Experiment Videos
Norfenfluramine and serotonin turnover rate in the rat brain
Biochemical Pharmacology
|September 1, 1972
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Diazepam-binding inhibitor (DBI)-processing products, acting at the mitochondrial DBI receptor, mediate adrenocorticotropic hormone-induced steroidogenesis in rat adrenal gland.
Proceedings of the National Academy of Sciences of the United States of America·1992
Building a bridge between neurobiology and mental illness.
Journal of psychiatric research·1992
Expression patterns of gamma-aminobutyric acid type A receptor subunit mRNAs in primary cultures of granule neurons and astrocytes from neonatal rat cerebella.
Proceedings of the National Academy of Sciences of the United States of America·1992
2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR).
The Journal of pharmacology and experimental therapeutics·1992
From intercellular communication to therapeutic delivery: Mechanistic perspectives of cancer exosomes.
Biochemical pharmacology·2026
A novel stilbene derivative targets RAD51 activity and sensitizes DU145 prostate cancer cells to cisplatin.
Biochemical pharmacology·2026
DNMT1 is associated with anti-PD-1 resistance and regulates the STAT3/PD-L1-CD8+ T-cell axis in melanoma.
Biochemical pharmacology·2026
Multi-tissue transcriptomic atlas reveals systemic effects of FGF19 on metabolism and immunity.
Biochemical pharmacology·2026
Targeting the NLRP3 inflammasome pathway associated with neuroinflammation mediated Alzheimer's disease: pre-clinical and clinical status of emerging therapeutics.
Expert opinion on therapeutic targets·2026
Relationship between retinal nerve fibre thickness, suprasellar extension and post-operative visual outcome in pituitary macroadenoma.
International journal of ophthalmology·2026
Closed-loop bioelectronic block of stellate ganglia reduces neurotransmitter release and improves recovery following programmed ventricular pacing.
Frontiers in bioengineering and biotechnology·2026